CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 261 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,424,000 | +83.1% | 186,900 | -1.1% | 0.00% | +200.0% |
| Q2 2022 | $1,324,000 | -15.5% | 188,911 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,566,000 | +22.1% | 188,911 | -0.3% | 0.00% | 0.0% |
| Q4 2021 | $1,283,000 | +13.6% | 189,511 | -11.0% | 0.00% | 0.0% |
| Q3 2021 | $1,129,000 | -6.8% | 213,006 | +1.0% | 0.00% | 0.0% |
| Q2 2021 | $1,212,000 | +109.3% | 210,806 | +67.9% | 0.00% | 0.0% |
| Q1 2021 | $579,000 | +28.4% | 125,590 | -6.9% | 0.00% | 0.0% |
| Q4 2020 | $451,000 | +12.5% | 134,827 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $401,000 | +281.9% | 134,827 | +492.5% | 0.00% | – |
| Q2 2020 | $105,000 | +1212.5% | 22,754 | +983.5% | 0.00% | – |
| Q4 2017 | $8,000 | – | 2,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |